Eubel Brady & Suttman Asset Management’s Pfizer PFE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-8,147	Closed	-$299K	–	94
2023 Q2	$299K	Buy	8,147 +27	+0.3%	+$1.05K	0.04%	76
2023 Q1	$331K	Buy	8,120 +12	+0.1%	+$518	0.05%	76
2022 Q4	$415K	Buy	8,108 +107	+1%	+$5.13K	0.07%	76
2022 Q3	$350K	Hold	8,001	–	–	0.06%	73
2022 Q2	$419K	Hold	8,001	–	–	0.08%	59
2022 Q1	$414K	Hold	8,001	–	–	0.08%	59
2021 Q4	$472K	Hold	8,001	–	–	0.09%	58
2021 Q3	$344K	Hold	8,001	–	–	0.07%	56
2021 Q2	$290K	Sell	8,001 -8,001	-50%	-$311K	0.03%	165
2021 Q1	$580K	Buy	16,002 +9,601	+150%	+$341K	0.06%	70
2020 Q4	$236K	Sell	6,401 -346	-5%	-$12.7K	0.06%	71
2020 Q3	$235K	Hold	6,747	–	–	0.06%	66
2020 Q2	$209K	Hold	6,747	–	–	0.05%	71
2020 Q1	$209K	Hold	6,747	–	–	0.06%	68
2019 Q4	$251K	Buy	6,747 +58	+0.9%	+$2.07K	0.07%	69
2019 Q3	$228K	Buy	6,689 +8	+0.1%	+$291	0.07%	69
2019 Q2	$275K	Buy	6,681 +6	+0.1%	+$238	0.08%	64
2019 Q1	$269K	Buy	6,675 +6	+0.1%	+$240	0.08%	61
2018 Q4	$276K	Buy	6,669 +16	+0.2%	+$664	0.09%	59
2018 Q3	$278K	Buy	6,653 +6	+0.1%	+$231	0.08%	62
2018 Q2	$229K	Sell	6,647 -8	-0.1%	-$273	0.07%	63
2018 Q1	$224K	Buy	6,655 +7	+0.1%	+$241	0.07%	60
2017 Q4	$228K	Sell	6,648 -23	-0.3%	-$784	0.07%	68
2017 Q3	$226K	Buy	6,671 +35	+0.5%	+$1.13K	0.07%	72
2017 Q2	$211K	Buy	6,636 +6	+0.1%	+$189	0.06%	73
2017 Q1	$215K	Buy	6,630 +56	+0.9%	+$1.77K	0.06%	69
2016 Q4	$203K	Buy	6,574 +7	+0.1%	+$214	0.06%	72
2016 Q3	$211K	Sell	6,567 -5	-0.1%	-$167	0.07%	74
2016 Q2	$220K	Buy	+6,572	New	+$210K	0.07%	69